Domov › Rakovina prostaty › Kansas
Klinické štúdie Rakovina prostaty v štáte Kansas
22 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Kansas.
Mestá v štáte Kansas
- Kansas City12 štúdií
- Topeka7 štúdií
- Overland Park7 štúdií
- Olathe5 štúdií
- Lawrence3 štúdií
- Wichita3 štúdií
- Pittsburg3 štúdií
Oficiálny text štúdie (anglicky)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- a 4 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- a 4 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- a 2 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- a 4 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382DESTINY-PANTUMOUR04
- Research Site, Topeka
Prebieha náborObservačná štúdia
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University of Kansas Hospital, Kansas City
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Kansas Medical Center, Westwood
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 9. 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Kansas Hospital, Kansas City
Prebieha náborFáza 3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06855277A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Kansas Medical Center, Kansas City
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 15. 9. 2026 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Wichita Urology Group, Wichita
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Kansas University Cancer Center, Kansas City
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 24. 8. 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- MidAmerica Cancer Care, Merriam
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 21. 8. 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Garden City, Garden City
- Mercy Hospital Pittsburg, Pittsburg
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 19. 8. 2026 · NCT04423211PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- University of Kansas Medical Center, Kansas City
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 7. 2026 · NCT06274047HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
- University of Kansas Health System, Kansas City
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT03802851Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699TERPS Trial for de Novo Oligometastic Prostate Cancer
- KU Medical Center- Cancer Center, Kansas City
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 3. 6. 2026 · NCT05223803Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Westwood
Prebieha náborFáza 1/2
Vek 18 až 130 · Muži · Aktualizované 23. 2. 2026 · NCT06267729A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 4. 2. 2026 · NCT04729114Vitamin D for Prostate Endocrine Therapy
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Health System Saint Francis Campus, Topeka
- a 1 ďalších
Prebieha náborFáza 3
Vek 50 a viac · Muži · Aktualizované 15. 1. 2026 · NCT05838716Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Olathe Health Cancer Center, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.